Skip to Content

Itoco Inc ITMC

Morningstar Rating
$0.01 0.00 (7.67%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ITMC is trading at a 70% premium.
Price
$0.01
Fair Value
$8.61
Uncertainty
Extreme
1-Star Price
$3.92
5-Star Price
$9.96
Economic Moat
Trl
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ITMC is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.01
Day Range
$0.010.01
52-Week Range
$0.000.04
Bid/Ask
$0.01 / $0.01
Market Cap
$3.25 Mil
Volume/Avg
378 / 24,484

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Itoco Inc is focused on developing and bringing biotech products to the market via co-development and joint venture arrangements with various companies. The company is currently examining various technologies that seek to control and/or identify bio-contaminants such as viruses and bacteria.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Total Number of Employees
47

Valuation

Metric
ITMC
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
ITMC
Quick Ratio
0.03
Current Ratio
0.18
Interest Coverage
−5.37
Quick Ratio
No chart available

Profitability

Metric
ITMC
Return on Assets (Normalized)
−118.92%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Novo Nordisk A/S ADR
NVO
YzbtqdyqGjkz$626.5 Bil
Vertex Pharmaceuticals Inc
VRTX
TzvpnzszJfvbkby$122.2 Bil
Regeneron Pharmaceuticals Inc
REGN
ZpdqgwhjcTmkfrjp$115.2 Bil
Moderna Inc
MRNA
PfhhghljShpj$52.8 Bil
argenx SE ADR
ARGX
RlynrgxKtlyz$23.0 Bil
BioNTech SE ADR
BNTX
WpjxdyxQhw$21.3 Bil
Alnylam Pharmaceuticals Inc
ALNY
ZqthsxxvyRhgcymz$19.9 Bil
Biomarin Pharmaceutical Inc
BMRN
QphhfgzhhDjgdmn$16.1 Bil
United Therapeutics Corp
UTHR
LjryzjvJfkl$13.2 Bil
Incyte Corp
INCY
RqztddqHfllcn$12.4 Bil

Sponsor Center